Currently, however, diagnosis is relatively simple, because G-CSF production in tumor cells can be demonstrated by measuring the serum G-CSF levels with enzyme immunoassay (EIA), or by immunohistochemical staining with rh-G-CSF antibodies [15]. This evidence concerns the gene CSF3 and neoplasm.